Rhythm Pharmaceuticals, Inc. (RYTM) Technical Analysis & Indicators

Rhythm Pharmaceuticals, Inc. (RYTM) — Price $86.44 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Rhythm Pharmaceuticals, Inc. (RYTM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R).

Price Performance

1 month+1.07%
3 months-16.65%
Year-to-date-12.71%
1 year-11.00%
3 years+246.46%
5 years+572.23%

52-Week Range

52-week High$122.20
52-week Low$74.50
Avg Volume (90d)691K

Technical Indicators

SMA 50$96.85
SMA 200$97.03
Beta2.14
30-day Volatility (annualised)26.3%
Price vs SMA 50-3.5%
Price vs SMA 200-3.7%

Monthly Close (12 months)

MonthCloseChange
2025-12$107.04
2026-01$102.52-4.2%
2026-02$92.73-9.5%
2026-03$86.97-6.2%
2026-04$81.36-6.5%
2026-05$88.32+8.6%
2026-06$111.03+25.7%
2026-07$99.25-10.6%
2026-08$106.13+6.9%
2026-09$95.22-10.3%
2026-10$92.57-2.8%
2026-11$93.44+0.9%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-11-03$-0.71$86M
2026-08-04$-0.81$68M
2026-05-05$-0.86$56M
2026-02-26$-0.79$56M
2025-11-04$-0.72$56M
2025-08-05$-0.66$51M

Price

Price$86.44 (closing price, November 3, 2026)
Market Cap$6.0B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book29.61
Dividend Yield0.00%

Financial Health

Debt / Equity0.02
Current Ratio2.78
Piotroski F-Score5
Altman Z-Score15.89

Related companies: BMRN · BLTE · VKTX · MBX · SEPN

Explore sector: Healthcare · Biotechnology

More sections of RYTM: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks